GATA2 is critical for the maintenance of cellular identity in differentiated mast cells derived from mouse bone marrow

Blood

Volumn 125, Issue 21, 2015, Pages 3306-3315

  Ohmori, ShiN'Ya ^a   Moriguchi, Takashi ^b   Noguchi, Yuki ^a   Ikeda, Muneharu ^a   Kobayashi, Kota ^a   Tomaru, Nazuki ^a   Ishijima, Yasushi ^a   Ohneda, Osamu ^c   Yamamoto, Masayuki ^b   Ohneda, Kinuko ^a  

^a TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; ANTIBODY; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD11B ANTIGEN; DNA BINDING PROTEIN; LY6G C ANTIBODY; MESSENGER RNA; STEM CELL FACTOR; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; GATA2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASOPHIL; BONE MARROW DERIVED MAST CELL; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL SPECIFICITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; EOSINOPHIL; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL FLUID; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR UPREGULATION; WILD TYPE; ANIMAL; BONE MARROW CELL; CELL DEDIFFERENTIATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; KNOCKOUT MOUSE; MAST CELL; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; GATA2 TRANSCRIPTION FACTOR; MAST CELLS; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 84962927313     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-11-612465     Document Type: Article

References (42)

1. Tsai FY, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 1997;89(10):3636-3643.
2. Masuda A, Hashimoto K, Yokoi T, et al. Essential role of GATA transcriptional factors in the activation of mast cells. J Immunol. 2007;178(1): 360-368.
3. Ohmori S, Takai J, Ishijima Y, et al. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages. Mol Cell Biol. 2012;32(23):4742-4755.
4. Ohneda K, Moriguchi T, Ohmori S, et al. Transcription factor GATA1 is dispensable for mast cell differentiation in adult mice. Mol Cell Biol. 2014;34(10):1812-1826.
5. Zon LI, Gurish MF, Stevens RL, et al. GATAbinding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene. J Biol Chem. 1991;266(34):22948-22953.
6. Nishiyama C, Yokota T, Okumura K, Ra C. The transcription factors Elf-1 and GATA-1 bind to cellspecific enhancer elements of human high-affinity IgE receptor alpha-chain gene. J Immunol. 1999; 163(2):623-630.
7. Maeda K, Nishiyama C, Tokura T, et al. Regulation of cell type-specific mouse Fc epsilon RI beta-chain gene expression by GATA-1 via four GATA motifs in the promoter. J Immunol. 2003;170(1):334-340.
8. Walsh JC, DeKoter RP, Lee HJ, et al. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity. 2002;17(5):665-676.
9. Salmon JM, Slater NJ, Hall MA, et al. Aberrant mast-cell differentiation in mice lacking the stemcell leukemia gene. Blood. 2007;110(10): 3573-3581.
10. Mukai K, BenBarak MJ, Tachibana M, et al. Critical role of P1-Runx1 in mouse basophil development. Blood. 2012;120(1):76-85.
11. Tshori S, Nechushtan H. Mast cell transcription factors-regulators of cell fate and phenotype. Biochim Biophys Acta. 2012;1822(1):42-48.
12. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA. 1997;94(2):569-574.
13. Dahl R, Walsh JC, Lancki D, et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colonystimulating factor. Nat Immunol. 2003;4(10): 1029-1036.
14. Iwasaki H, Somoza C, Shigematsu H, et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood. 2005;106(5):1590-1600.
15. Charles MA, Saunders TL, Wood WM, et al. Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol Endocrinol. 2006;20(6):1366-1377.
16. Zhang P, Iwasaki-Arai J, Iwasaki H, et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity. 2004;21(6):853-863.
17. Ishijima Y, Ohmori S, Uenishi A, Ohneda K. GATA transcription factors are involved in IgEdependent mast cell degranulation by enhancing the expression of phospholipase C-γ1. Genes Cells. 2012;17(4):285-301.
18. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol. 2008;83(1):64-70.
19. Springer T, Galfré G, Secher DS, Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol. 1979; 9(4):301-306.
20. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol. 1981;11(10): 805-815.
21. Hume DA, Robinson AP, MacPherson GG, Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J Exp Med. 1983;158(5): 1522-1536.
22. Ford AM, Bennett CA, Healy LE, Towatari M, Greaves MF, Enver T. Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBP alpha, -beta, and -delta during granulocyte-lineage specification. Proc Natl Acad Sci USA. 1996;93(20):10838-10843.
23. Arinobu Y, Iwasaki H, Gurish MF, et al. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA. 2005;102(50):18105-18110.
24. Qi X, Hong J, Chaves L, et al. Antagonistic regulation by the transcription factors C/EBPa and MITF specifies basophil and mast cell fates. Immunity. 2013;39(1):97-110.
25. Iwasaki H, Mizuno S, Arinobu Y, et al. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev. 2006;20(21):3010-3021.
26. Poorafshar M, Helmby H, Troye-Blomberg M, Hellman L. MMCP-8, the first lineage-specific differentiation marker for mouse basophils. Elevated numbers of potent IL-4-producing and MMCP-8-positive cells in spleens of malariainfected mice. Eur J Immunol. 2000;30(9): 2660-2668.
27. Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, Paul WE. B cell stimulatory factor-1/ interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell. 1987;50(5):809-818.
28. Gutiérrez L, Nikolic T, van Dijk TB, et al. Gata1 regulates dendritic-cell development and survival. Blood. 2007;110(6):1933-1941.
29. Dyer KD, Moser JM, Czapiga M, Siegel SJ, Percopo CM, Rosenberg HF. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol. 2008;181(6):4004-4009.
30. Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ, Hamilton JA. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol. 2009;86(2):411-421.
31. de la Luz Sierra M, Sakakibara S, Gasperini P, et al. The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1. Blood. 2010; 115(19):3970-3979.
32. Motakis E, Guhl S, Ishizu Y, et al; FANTOM consortium. Redefinition of the human mast cell transcriptome by deep-CAGE sequencing. Blood. 2014;123(17):e58-e67.
33. Guo H, Ma O, Speck NA, Friedman AD. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis. Blood. 2012;119(19):4408-4418.
34. Rao KN, Smuda C, Gregory GD, Min B, Brown MA. Ikaros limits basophil development by suppressing C/EBP-α expression. Blood. 2013; 122(15):2572-2581.
35. Guo H, Ma O, Friedman AD. The Cebpa 137-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells. J Leukoc Biol. 2014;96(3):419-426.
36. Arinobu Y, Iwasaki H, Akashi K. Origin of basophils and mast cells. Allergol Int. 2009;58(1): 21-28.
37. Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA. 2005; 102(32):11408-11413.
38. Franco CB, Chen CC, Drukker M, Weissman IL, Galli SJ. Distinguishing mast cell and granulocyte differentiation at the single-cell level. Cell Stem Cell. 2010;6(4):361-368.
39. Cantor AB, Iwasaki H, Arinobu Y, et al. Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage. J Exp Med. 2008; 205(3):611-624.
40. Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui AL, Kitamura T. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 1999;18(17): 4754-4765.
41. Kitamura T, Koshino Y, Shibata F, et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol. 2003;31(11):1007-1014.
42. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7(12): 1063-1066.